-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on IDEAYA Biosciences, Lowers Price Target to $59

Benzinga·08/05/2026 18:18:38
语音播报
Truist Securities analyst Gregory Renza maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $63 to $59.